Xcellerex gains $11M in new venture funds

Marlborough, MA-based Xcellerex announced on Friday that that it had raised $11 million in the second tranche of its second round of venture financing. Xcellerex is commercializing a new manufacturing program that uses disposable components to produce multiple products. SCG Group and Kleiner Perkins Caufield and Byers led the round while Kleiner Perkins' Thomas Monath, M.D., joined the Xcellerex board of directors.

"We have built a customer base of top tier pharmaceutical and biotechnology companies," said Xcellerex CEO Mike Masterson. "The funds will allow us to expand our commercial efforts in the vaccine and biotherapeutic markets."

- here's the release